These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3304187)

  • 21. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel.
    Valanis BG; Vollmer WM; Labuhn KT; Glass AG
    Am J Hosp Pharm; 1993 Mar; 50(3):455-62. PubMed ID: 8442461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nurses' exposure to cytostatics in the handling of cytostatics. Theoretical lesson and clinical study].
    Johansson I; Bergenfelz A; Wadbo M
    SHSTF; 1981 Aug; (7):1-29. PubMed ID: 6914812
    [No Abstract]   [Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occupational exposure to anticancer drug--potential and real hazards.
    Sorsa M; Hemminki K; Vainio H
    Mutat Res; 1985 Sep; 154(2):135-49. PubMed ID: 3929080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nurses' protective measures during chemotherapy preparation and administration in Turkey*.
    Rizalar S; Tural E; Altay B
    Int J Nurs Pract; 2012 Feb; 18(1):91-8. PubMed ID: 22257336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safe handling of antineoplastic drugs. Results of a survey.
    Nieweg RM; de Boer M; Dubbleman RC; Gall HE; Hesselman GM; Lenssen PC; van Maanen LW; Majoor PW; Ouwerkerk J; Slegt JH
    Cancer Nurs; 1994 Dec; 17(6):501-11. PubMed ID: 7820828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations.
    Pethran A; Schierl R; Hauff K; Grimm CH; Boos KS; Nowak D
    Int Arch Occup Environ Health; 2003 Feb; 76(1):5-10. PubMed ID: 12592576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytogenetic indicators of genotoxicity in subjects occupationally exposed to antineoplastic drugs].
    Forni A; Bonatti S; Merler E
    Med Lav; 1996; 87(3):222-9. PubMed ID: 8965735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An investigation on the chromosomal damage in nurses occupationally exposed to antineoplastic drugs].
    Xu SJ; Wang JX; Yang DP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):119-20. PubMed ID: 12839665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotoxicity of environmental agents assessed by the alkaline comet assay.
    Møller P
    Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Teratogenic and mutagenic risks of radiotherapy: when and how to prescribe contraception].
    Marty M; Mignot L; Gisselbrecht G; Morvan F; Gorins A; Boiron M
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):181-6. PubMed ID: 12280202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic effects and biotoxicity monitoring of occupational styrene exposure.
    Rueff J; Teixeira JP; Santos LS; Gaspar JF
    Clin Chim Acta; 2009 Jan; 399(1-2):8-23. PubMed ID: 18845133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy-handling practices of outpatient and office-based oncology nurses.
    Martin S; Larson E
    Oncol Nurs Forum; 2003; 30(4):575-81. PubMed ID: 12861318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide.
    Sugiura S; Asano M; Kinoshita K; Tanimura M; Nabeshima T
    J Oncol Pharm Pract; 2011 Mar; 17(1):14-9. PubMed ID: 20179165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risks of using cytostatic drugs in veterinary medical practice].
    Pellicaan CH; Teske E
    Tijdschr Diergeneeskd; 1999 Apr; 124(7):210-5. PubMed ID: 10214684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Summary of recommendations for a rational implementation of the ministry of health guidelines on the prevention of occupational risks in handling antineoplastic agents].
    Gruppo di Lavoro dell'Associazione Italiana di Medicina Preventiva dei Lavoratori della Sanità
    Med Lav; 2001; 92(2):137-48. PubMed ID: 11441591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes.
    Fransman W; Roeleveld N; Peelen S; de Kort W; Kromhout H; Heederik D
    Epidemiology; 2007 Jan; 18(1):112-9. PubMed ID: 17099323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute symptoms associated with antineoplastic drug handling among nurses.
    Valanis BG; Vollmer WM; Labuhn KT; Glass AG
    Cancer Nurs; 1993 Aug; 16(4):288-95. PubMed ID: 8402605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Turkish nurses' information about, and administration of, chemotherapeutic drugs.
    Kosgeroglu N; Ayranci U; Ozerdogan N; Demirustu C
    J Clin Nurs; 2006 Sep; 15(9):1179-87. PubMed ID: 16911059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.